Summary
IDEXX Laboratories, Inc. (IDXX) filed a Form 8-K on October 31, 2017, to report its financial results for the third quarter ended September 30, 2017. The report primarily furnishes a press release detailing these results, which is attached as an exhibit. Investors should note that this information, while important for understanding the company's performance, is furnished under Item 2.02 and therefore is not considered "filed" under Section 18 of the Exchange Act, meaning it doesn't carry the same liabilities if found to be inaccurate or misleading. The core of this filing is the announcement of IDEXX's Q3 2017 performance. While the specific financial figures are contained within the press release (Exhibit 99.1), this 8-K serves as the official notification to the market about these results. Investors should refer to the furnished press release for details on revenue, earnings, and any forward-looking guidance provided by the company. The filing also confirms the CFO, Brian P. McKeon, signed off on the report.
Key Highlights
- 1IDEXX Laboratories announced its financial results for the third quarter ended September 30, 2017.
- 2The company furnished a press release (Exhibit 99.1) containing the detailed Q3 financial results.
- 3The information is furnished under Item 2.02 of Form 8-K and is not deemed "filed" for Section 18 purposes.
- 4The filing date was October 31, 2017, coinciding with the press release issuance date.
- 5The report includes the signature of the Executive Vice President, Chief Financial Officer, and Treasurer, Brian P. McKeon.
- 6Investors are directed to the press release for specific performance metrics and financial details.